VANESSA PAGE: Open Payments
NPI 1932622115 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,702 in 80 payments from 24 companies in 2025. Trend: 2023 $266 · 2024 $957 · 2025 $1,702
Food & beverage: $1,484Education: $217
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $184 |
| GlaxoSmithKline, LLC. | 7 | $177 |
| ABBVIE INC. | 5 | $155 |
| E.R. Squibb & Sons, L.L.C. | 8 | $130 |
| TAIHO ONCOLOGY, INC. | 6 | $120 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Gilead Sciences, Inc. | 1 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| PFIZER INC. | 3 | $67 |
| Merck Sharp & Dohme LLC | 3 | $63 |
Products named: OJJAARA, Enhertu, IMBRUVICA, LONSURF, OPDIVO, Trodelvy, INJECTAFER, XTANDI.
Industry payments across AZ — which companies pay providers there.
